Researchers, led by Joana Reis, examined the diagnostic accuracy of magnetic resonance imaging (MRI) for detecting ... The phase II MAINTAIN trial evaluated the efficacy of adding ribociclib to endocrine therapy in patients with hormone ... Screening for patient-reported quality of life factors may help to identify patients who are at increased risk for early ... Circulating tumor cell (CTC) count may be an effective biomarker for deciding between chemotherapy and endocrine therapy ... A new study examined factors associated with non-adherence to endocrine therapy among breast cancer patients.
... A recent study published in JAMA Oncology analyzed outcomes for patients with early breast cancer with a high 21-gene ... According to a study published in Nature Communications, adjuvant endocrine therapy for breast cancer may only force ... Certain women who receive menopausal hormone therapy may have a greater risk for breast cancer, according to a new ... A study published in JAMA Oncology found that tamoxifen produced a long-term protective affect for women with luminal A ...